Insmed Inc. buy JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€22.40
Target price
20.11.24
€32.94
Performance (%)
203.57%
End price
21.11.24
€68.00
Summary
This prediction ended on 21.11.24 with a price of €68.00. With a performance of 203.57% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 32.677% | 32.677% | 21.027% |
| iShares Core DAX® | 1,00 % | 4,83 % | 8,15 % |
| iShares Nasdaq 100 | 2,70 % | -1,72 % | 26,92 % |
| iShares Nikkei 225® | 3,52 % | -3,51 % | 48,06 % |
| iShares S&P 500 | 1,77 % | 1,27 % | 23,58 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $36.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten